Evaluation of bioprinter technologies

Ibrahim Tarik Ozbolat, Kazim K. Moncal, Hemanth Gudapati

Research output: Contribution to journalReview article

44 Citations (Scopus)

Abstract

Since the first printing of biologics with cytoscribing as demonstrated by Klebe in 1986, three dimensional (3D) bioprinting has made a substantial leap forward, particularly in the last decade. It has been widely used in fabrication of living tissues for various application areas such as tissue engineering and regenerative medicine research, transplantation and clinics, pharmaceutics and high-throughput screening, and cancer research. As bioprinting has gained interest in the medical and pharmaceutical communities, the demand for bioprinters has risen substantially. A myriad of bioprinters have been developed at research institutions worldwide and several companies have emerged to commercialize advanced bioprinter technologies. This paper prefaces the evolution of the field of bioprinting and presents the first comprehensive review of existing bioprinter technologies. Here, a comparative evaluation is performed for bioprinters; limitations with the current bioprinter technologies are discussed thoroughly and future prospects of bioprinters are provided to the reader.

Original languageEnglish (US)
Pages (from-to)179-200
Number of pages22
JournalAdditive Manufacturing
Volume13
DOIs
StatePublished - Jan 1 2017

Fingerprint

Transplantation (surgical)
Biological Products
Tissue engineering
Pharmaceutical Preparations
Drug products
Printing
Screening
Throughput
Tissue
Fabrication
Industry
Regenerative Medicine

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Materials Science(all)
  • Engineering (miscellaneous)
  • Industrial and Manufacturing Engineering

Cite this

Ozbolat, Ibrahim Tarik ; Moncal, Kazim K. ; Gudapati, Hemanth. / Evaluation of bioprinter technologies. In: Additive Manufacturing. 2017 ; Vol. 13. pp. 179-200.
@article{8813fbbe8aa546439b4c0007e9ec7dec,
title = "Evaluation of bioprinter technologies",
abstract = "Since the first printing of biologics with cytoscribing as demonstrated by Klebe in 1986, three dimensional (3D) bioprinting has made a substantial leap forward, particularly in the last decade. It has been widely used in fabrication of living tissues for various application areas such as tissue engineering and regenerative medicine research, transplantation and clinics, pharmaceutics and high-throughput screening, and cancer research. As bioprinting has gained interest in the medical and pharmaceutical communities, the demand for bioprinters has risen substantially. A myriad of bioprinters have been developed at research institutions worldwide and several companies have emerged to commercialize advanced bioprinter technologies. This paper prefaces the evolution of the field of bioprinting and presents the first comprehensive review of existing bioprinter technologies. Here, a comparative evaluation is performed for bioprinters; limitations with the current bioprinter technologies are discussed thoroughly and future prospects of bioprinters are provided to the reader.",
author = "Ozbolat, {Ibrahim Tarik} and Moncal, {Kazim K.} and Hemanth Gudapati",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.addma.2016.10.003",
language = "English (US)",
volume = "13",
pages = "179--200",
journal = "Additive Manufacturing",
issn = "2214-8604",
publisher = "Elsevier BV",

}

Evaluation of bioprinter technologies. / Ozbolat, Ibrahim Tarik; Moncal, Kazim K.; Gudapati, Hemanth.

In: Additive Manufacturing, Vol. 13, 01.01.2017, p. 179-200.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Evaluation of bioprinter technologies

AU - Ozbolat, Ibrahim Tarik

AU - Moncal, Kazim K.

AU - Gudapati, Hemanth

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Since the first printing of biologics with cytoscribing as demonstrated by Klebe in 1986, three dimensional (3D) bioprinting has made a substantial leap forward, particularly in the last decade. It has been widely used in fabrication of living tissues for various application areas such as tissue engineering and regenerative medicine research, transplantation and clinics, pharmaceutics and high-throughput screening, and cancer research. As bioprinting has gained interest in the medical and pharmaceutical communities, the demand for bioprinters has risen substantially. A myriad of bioprinters have been developed at research institutions worldwide and several companies have emerged to commercialize advanced bioprinter technologies. This paper prefaces the evolution of the field of bioprinting and presents the first comprehensive review of existing bioprinter technologies. Here, a comparative evaluation is performed for bioprinters; limitations with the current bioprinter technologies are discussed thoroughly and future prospects of bioprinters are provided to the reader.

AB - Since the first printing of biologics with cytoscribing as demonstrated by Klebe in 1986, three dimensional (3D) bioprinting has made a substantial leap forward, particularly in the last decade. It has been widely used in fabrication of living tissues for various application areas such as tissue engineering and regenerative medicine research, transplantation and clinics, pharmaceutics and high-throughput screening, and cancer research. As bioprinting has gained interest in the medical and pharmaceutical communities, the demand for bioprinters has risen substantially. A myriad of bioprinters have been developed at research institutions worldwide and several companies have emerged to commercialize advanced bioprinter technologies. This paper prefaces the evolution of the field of bioprinting and presents the first comprehensive review of existing bioprinter technologies. Here, a comparative evaluation is performed for bioprinters; limitations with the current bioprinter technologies are discussed thoroughly and future prospects of bioprinters are provided to the reader.

UR - http://www.scopus.com/inward/record.url?scp=85006954183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006954183&partnerID=8YFLogxK

U2 - 10.1016/j.addma.2016.10.003

DO - 10.1016/j.addma.2016.10.003

M3 - Review article

AN - SCOPUS:85006954183

VL - 13

SP - 179

EP - 200

JO - Additive Manufacturing

JF - Additive Manufacturing

SN - 2214-8604

ER -